NCT02671760View on ClinicalTrials.gov

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

PHASE2CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Short-term Insomnia

Interventions

DRUG

SM-1

3-drug combination product containing 50 mg diphenhydramine, 5 mg zolpidem and 0.5 mg lorazepam

DRUG

Comparator

2-drug combination comprised of 5 mg zolpidem and 0.5 mg lorazepam

DRUG

Placebo

Placebo

Sponsors

Collaborators (1)

Clinilabs, Inc.

All Listed Sponsors

collaborator

Clinilabs, Inc.

OTHER

lead

Sequential Medicine Ltd

INDUSTRY

NCT02671760 - Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia | Biotech Hunter | Biotech Hunter